Effects of the Dietary Inflammatory Index on Systemic Inflammation Markers and Gastrointestinal Symptoms in Individuals With Bariatric Surgery

NCT07293624 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-12-19

No results posted yet for this study

Summary

The goal of this observational cross-sectional study is to evaluate the relationships between the Dietary Inflammatory Index (DII), systemic inflammatory markers, and gastrointestinal symptoms in adults aged 18-65 who have undergone bariatric surgery.

The main questions it aims to answer are:

Does the inflammatory potential of the diet affect systemic inflammation levels (such as SII, CRP, and WBC) in the post-operative period?

Is there an association between the DII score and gastrointestinal symptoms (e.g., bloating, gas, abdominal pain)?

Participants who are at least three months post-bariatric surgery will provide dietary intake data to calculate DII scores, undergo blood tests to measure inflammatory markers, and complete assessments regarding their gastrointestinal symptoms.

Conditions

  • Bariatric Surgery
  • Bariatric Sleeve Gastrectomy
  • Inflamation
  • Systemic Inflammation
  • Dietary Inflammatory Index (DII)
  • Systemic Inflammation Markers

Interventions

OTHER

Observational Intervention

This is cross sectional observational study.

OTHER

Observetional

This is cross-sectional study. Questionnaire, Dietary Inflammatory Index (DII), systemic inflammatory markers, and gastrointestinal symptoms will be investigated.

Sponsors & Collaborators

  • Istanbul Bilgi University

    lead OTHER

Principal Investigators

  • Hande Seven Avuk, Ph.D. · Istanbul Bilgi University

  • Gökben Anıl · Haliç University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-06-01
Completion
2026-07-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07293624 on ClinicalTrials.gov